What's New

NIH	Request for Information (RFI): Increasing the diversity of applications to the NIH Common Fund High-Risk, High-Reward Research Program	The purpose of this Request for Information (RFI) is to solicit information from the broad community about factors that lead to underrepresentation of certain groups in the applicant pool of the Common Fund’s High-Risk, High-Reward Research Program and approaches that the NIH might take to increase applicant diversity.
NIDDK	dkNET: Connecting Researchers to Resources	The NIDDK Information Network (dkNET), is a search portal and information hub that helps researchers find research resources and data repositories relevant to their research and keep up to date on new tools, services and mandates to support robust and reproducible science, including funding opportunities, resource authentication and data sharing.
	Summer 2019 Type 2 Diabetes Knowledge Portal Newsletter	The Summer 2019 T2D Knowledge Portal Newsletter lists upcoming webinars, new videos, and venues, plus articles on mining genomic data, genetic association analysis, and burden test improvements.
NIDDK	Request for Information (RFI): Regarding Bioinformatics/Computational Needs for NIDDK Investigators Engaged in Diabetes, Endocrinology and Metabolic Diseases Research	The National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) invites interested investigators to provide input on their needs for bioinformatics/computational support to advance R01-based research in Diabetes, Endocrinology and Metabolic Diseases. Responses to this RFI will be accepted through October 15, 2019.
NIDDK	NIDDK Special Job Announcements 2019	The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH), are looking for applicants with significant research experience, who have a commitment to excellence, and the energy, enthusiasm, and innovative thinking necessary to lead dynamic and diverse programs. Applicants must be U.S. Citizens.
NIDDK	Dr. William T. Cefalu to direct NIDDK Division of Diabetes, Endocrinology, and Metabolic Diseases	NIDDK Director Dr. Griffin P. Rodgers announces Dr. William T. Cefalu as the new director of the Division of Diabetes, Endocrinology, and Metabolic Diseases at the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases. An expert physician researcher, leader, and patient advocate, Dr. Cefalu will be responsible for setting scientific priorities within a large and diverse program of basic and clinical research.
NIH	NIH HRHR program initiatives - Upcoming Webinars	Notice of Pre-Application Webinars for the High-Risk, High-Reward Research Program's Pioneer (RFA-RM-19-005), New Innovator (RFA-RM-19-006), Transformative Research (RFA-RM-19-007), and Early Independence (RFA-RM-19-008) Awards.
NIH	Drug delays type 1 diabetes in people at high risk	A treatment affecting the immune system effectively slowed the progression to clinical type 1 diabetes in high risk individuals, according to findings from National Institutes of Health-funded research. The study is the first to show that clinical type 1 diabetes can be delayed by two or more years among people who are at high risk.
NIH	Improvements in insulin release wane after treatment stops in adults with early type 2 diabetes	A set of clinical trials examining youth and adults with type 2 diabetes or impaired glucose tolerance has found that disease progression in adults slowed during medical treatment but resumed after treatment stopped. Youth on the same treatment had markedly poorer outcomes with continued disease progression both during and after the treatment.
NIH	NIH-funded trial finds vitamin D does not prevent type 2 diabetes in people at high risk	Taking a daily vitamin D supplement does not prevent type 2 diabetes in adults at high risk, according to results from a study funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. The Vitamin D and Type 2 Diabetes (D2d) study enrolled 2,423 adults and was conducted at 22 sites across the United States.
NIH	NIH study finds heavily processed foods cause overeating and weight gain	People eating ultra-processed foods ate more calories and gained more weight than when they ate a minimally processed diet, according to results from a National Institutes of Health study. The difference occurred even though meals provided to the volunteers in both the ultra-processed and minimally processed diets had the same number of calories and macronutrients.
NIH	Daily folic acid supplement may reduce risk of gestational diabetes	Taking a folic acid supplement daily before pregnancy may reduce the risk of gestational, or pregnancy-related, diabetes, according to a study by researchers at the National Institutes of Health and other institutions. The findings appear in Diabetes Care.